Lantern Pharma Inc (LTRN)

05:45 AM

Lantern Pharma concludes patient enrolment for trial of LP-300 in Japan - Yahoo Finance

05:45 AM

Jul 31, 2025

Lantern Pharma (NASDAQ: LTRN) Completes Targeted Enrollment for Phase 2 HARMONIC Trial in Japan - Barchart.com

Jul 31, 2025

Jul 31, 2025

Lantern Pharma's Strategic Expansion in Japan: A Catalyst for Near-Term Stock Appreciation - AInvest

Jul 31, 2025

Jul 31, 2025

Lantern Pharma completes Japanese enrollment in lung cancer trial By Investing.com - Investing.com India

Jul 31, 2025

Jul 31, 2025

Lantern Pharma Completes Targeted Enrollment for Lung Cancer Phase 2 Harmonic™ Clinical Trial in Japan for LP-300 - Business Wire

Jul 31, 2025

Jul 31, 2025

How volatile is Lantern Pharma Inc. stock compared to the marketEntry Signal Forecasts For Consistent Profits - jammulinksnews.com

Jul 31, 2025

Jul 30, 2025

Lantern Pharma Appoints Dr. Schalop to Board - MSN

Jul 30, 2025

Jul 30, 2025

Why Lantern Pharma Inc. stock attracts strong analyst attentionRisk Limited High Gain Trades - beatles.ru

Jul 30, 2025

Jul 29, 2025

How Lantern Pharma Inc. stock performs during market volatilityWatchlist for Low Risk High Return Stocks Updated - metal.it

Jul 29, 2025

Jul 29, 2025

Lantern Pharma Inc. Could See a Relief Rally From SupportSwing Trade Plans Emphasize Risk Management - metal.it

Jul 29, 2025

Jul 29, 2025

Applying Wyckoff theory to Lantern Pharma Inc. stockInvestment Plan With Growth Optimization Finalized - metal.it

Jul 29, 2025

Jul 29, 2025

Lantern Pharma appoints Lee T. Schalop, M.D. to board and amends quorum rules - Investing.com

Jul 29, 2025

Jul 29, 2025

Lantern Pharma Announces Appointment of Dr. Lee Schalop to Board of Directors - BioSpace

Jul 29, 2025

Jul 29, 2025

Lantern Pharma Strengthens Board with AI and Oncology Expert Dr. Lee T. Schalop - citybuzz -

Jul 29, 2025

Jul 29, 2025

Lantern Pharma Inc. Stock Fails to Break Resistance Traders ReactLow Risk High Return Opportunities Identified - metal.it

Jul 29, 2025

Jul 28, 2025

What makes Lantern Pharma Inc. stock price move sharplyDaily Trading Outlook With Proven Results - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

Published on: 2025-07-28 22:46:11 - metal.it

Jul 28, 2025

Jul 28, 2025

Lantern Pharma (NASDAQ: LTRN) Appoints Dr. Lee T. Schalop to Board to Bolster AI-Driven Precision Oncology - The Globe and Mail

Jul 28, 2025

Jul 28, 2025

Lantern Pharma Appoints Dr. Lee Schalop To Board - citybiz

Jul 28, 2025

Jul 28, 2025

What institutional investors are buying Lantern Pharma Inc. stockInvest confidently with professional market insights - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

Lantern Pharma appoints biotech executive Lee Schalop to board By Investing.com - Investing.com Nigeria

Jul 28, 2025

Jul 28, 2025

Lantern Pharma appoints biotech executive Lee Schalop to board - Investing.com

Jul 28, 2025

Jul 28, 2025

What institutional flow reveals about Lantern Pharma Inc.Portfolio Booster Strategy with Trend Confidence - Newser

Jul 28, 2025

Jul 28, 2025

How Lantern Pharma Inc. stock performs during market volatility Weekly Signal Report with Trend Summary - Newser

Jul 28, 2025

Jul 28, 2025

What are the latest earnings results for Lantern Pharma Inc.Unlock exclusive stock analysis for investors - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

What are analysts’ price targets for Lantern Pharma Inc. in the next 12 monthsBuild a diversified portfolio for risk mitigation - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Is Lantern Pharma Inc. stock overvalued or undervaluedIdentify safe investments with exceptional yields - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Is it the right time to buy Lantern Pharma Inc. stockExtraordinary market timing - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Is Lantern Pharma Inc. Stock Overbought or Oversold RSI Indicator AnalysisFree Stock Selection with 300% Return - Newser

Jul 27, 2025

Jul 27, 2025

Intrinsic Value of Lantern Pharma Inc. Stock: Is It Undervalued or OvervaluedFree Discussion Group - Newser

Jul 27, 2025

Jul 27, 2025

How Resilient Is Lantern Pharma Inc. Stock During Economic DownturnsHigh Potential Safe Trades - Newser

Jul 27, 2025

Jul 26, 2025

Lantern Pharma secures EU patent for AI-driven cancer drug LP-284 - MSN

Jul 26, 2025

Jul 25, 2025

Published on: 2025-07-26 01:13:11 - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

What analysts say about Lantern Pharma Inc. stockRapid growth opportunities - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Lantern Pharma Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Bellingham Herald

Jul 25, 2025

Jul 25, 2025

Is Lantern Pharma Inc. a good long term investmentFree Stock Market Real-Time Monitoring - Autocar Professional

Jul 25, 2025

Jul 25, 2025

Will Lantern Pharma Inc. stock benefit from interest rate changesExceptional gains - jammulinksnews.com

Jul 25, 2025

Jul 24, 2025

Why Lantern Pharma Inc. stock is on top investor watchlistsOverwhelming financial success - jammulinksnews.com

Jul 24, 2025

Jul 24, 2025

Lantern Pharma Inc. Stock Analysis and ForecastBreakthrough stock performance - Autocar Professional

Jul 24, 2025

Jul 23, 2025

What drives Lantern Pharma Inc. stock priceTremendous gains - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Lantern Pharma (NASDAQ: LTRN) Reports First Complete Response in Phase 1 LP-284 Trial for Aggressive DLBCL - Barchart.com

Jul 23, 2025

Jul 23, 2025

Lantern Pharma reports complete response in aggressive lymphoma patient - Investing.com Australia

Jul 23, 2025

Jul 23, 2025

Lantern Pharma reports complete response in aggressive lymphoma patient By Investing.com - Investing.com South Africa

Jul 23, 2025

Jul 23, 2025

Lantern Pharma Reports Complete Response in Heavily Pre-Treated Lymphoma Patient with LP-284 in Phase 1 Clinical Trial - Business Wire

Jul 23, 2025